An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andrew Allegretti, M.D.
Massachusetts General Hospital
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
87 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Clinical Research Site
Birmingham, Alabama, United States
- Clinical Research Site
Birmingham, Alabama, United States
- Clinical Research Site
Birmingham, Alabama, United States
- Clinical Research Site
Foley, Alabama, United States
- Clinical Research Site
Gulf Shores, Alabama, United States
- Clinical Research Site
Glendale, Arizona, United States
- Clinical Research Site
Mesa, Arizona, United States
- Clinical Research Site
Phoenix, Arizona, United States
- Clinical Research Site
Tucson, Arizona, United States
- Clinical Research Site
Anaheim, California, United States
- Clinical Research Site
Bellflower, California, United States
- Clinical Research Site
Fair Oaks, California, United States
- Clinical Research Site
Fresno, California, United States
- Clinical Research Site
Lincoln, California, United States
- Clinical Research Site
Los Angeles, California, United States
- Clinical Research Site
San Gabriel, California, United States
- Clinical Research Site
Santa Rosa, California, United States
- Clinical Research Site
Upland, California, United States
- Clinical Research Site
Colorado Springs, Colorado, United States
- Clinical Research Site
Colorado Springs, Colorado, United States
- Clinical Research Site
Denver, Colorado, United States
- Clinical Research Site
Golden, Colorado, United States
- Clinical Research Site
Stamford, Connecticut, United States
- Clinical Research Site
Decatur, Georgia, United States
- Clinical Research Site
Decatur, Georgia, United States
- Clinical Research Site
Lithonia, Georgia, United States
- Clinical Research Site
Chicago, Illinois, United States
- Clinical Research Site
Chicago, Illinois, United States
- Clinical Research Site
Chicago, Illinois, United States
- Clinical Research Site
Avon, Indiana, United States
- Clinical Research Site
Evansville, Indiana, United States
- Clinical Research Site
Indianapolis, Indiana, United States
- Clinical Research Site
Council Bluffs, Iowa, United States
- Clinical Research Site
Prairie Village, Kansas, United States
- Clinical Research Site
Lexington, Kentucky, United States
- Clinical Research Site
Paducah, Kentucky, United States
- Clinical Research Site
Versailles, Kentucky, United States
- Clinical Research Site
New Orleans, Louisiana, United States
- Clinical Research Site
Auburn, Maine, United States
- Clinical Research Site
Silver Spring, Maryland, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Oct 2017
- Primary completion
- 30 Nov 2018
- Completion
- 30 Nov 2018
- Last update posted
- 21 Sept 2021
- Registered enrollment
- 673
- Registry id
- NCT03514641
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.